Results 31 to 40 of about 1,293,284 (282)

Costs incurred by patients with oral potentially malignant disorders: is there a public health need for financial protection in India?

BMC Research Notes, 2021
Objectives Financial protection mechanisms are in place to overcome the costs of a few diseases in India. Our objective was to estimate the costs incurred due to Oral Potentially Malignant Disorders (OPMD) and to determine predictors of such costs ...
Jay R. Patel, Mihir P. Rupani
doaj   +1 more source

Health resource utilization and the economic burden of patients with wet age-related macular degeneration in Thailand

International Journal of Ophthalmology, 2014
AIM:To determine healthcare resource utilization and the economic burden associated with wet age-related macular degeneration (AMD) in ThailandMETHODS:This study included patients diagnosed with wet AMD that were 60 years old or older, and had best ...
Piyameth Dilokthornsakul, Nathorn Chaiyakunapruk, Paisan Ruamviboonsuk, Mansing Ratanasukon, Somsanguan Ausayakhun, Akrapope Tungsomeroengwong, Nattapol Pokawattana, Chalakorn Chanatittarat   +7 more
doaj   +1 more source

The trend of direct medical costs and associated factors in patients with chronic hepatitis B in Guangzhou, China: an eight-year retrospective cohort study

BMC Medical Informatics and Decision Making, 2021
Background Although the expenses of liver cirrhosis are covered by a critical illness fund under the current health insurance program in China, the medical costs associated with hepatitis B virus (HBV) related diseases is not well addressed.
Shuo Yang, Ge Chen, Yueping Li, Guanhai Li, Yingfang Liang, Feng Zhou, Shudong Zhou, Yi Yang, Weidong Jia, Yanhui Gao, Yue Chen   +10 more
doaj   +1 more source

Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis [PDF]

, 2014
Background: The burden of disease due to S. pneumoniae (pneumococcus), particularly pneumonia, remains high despite the widespread use of vaccines. Drug resistant strains complicate clinical treatment and may increase costs.
Finkelstein, Jonathan A, Huang, Susan S, Moore, Matthew R, Ray, G Thomas, Reynolds, Courtney A   +4 more
core   +3 more sources

TB Fast Track patient cost data [PDF]

, 2018
A tabular dataset containing information provided by 99 HIV-positive individuals – men and women aged 18 or above who had a low CD4 count and were not yet on TB or HIV treatment - enrolled in the TB FastTrack trial, a cluster randomised trial to ...
Candfield, Sophie, Charalambous, Salome, Fielding, Katherine, Grant, Alison D., Monkwe, Sefalane, Mukora, Rachel, Sweeney, Sedona, Vassall, Anna   +7 more
core   +1 more source

Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study

JHEP Reports, 2020
Background & Aims: Non-alcoholic steatohepatitis (NASH) leads to cirrhosis and is associated with a substantial socioeconomic burden, which, coupled with rising prevalence, is a growing public health challenge.
Jamie O'Hara, Alan Finnegan, Harpal Dhillon, Leonardo Ruiz-Casas, Gabriel Pedra, Bethany Franks, George Morgan, Vanessa Hebditch, Bengt Jönsson, Mzwandile Mabhala, Tatjana Reic, Ingo Van Thiel, Vlad Ratziu, Manuel Romero-Gomez, Elisabetta Bugianesi, Jörn M. Schattenberg, Quentin M. Anstee   +16 more
doaj   +1 more source

Societal costs and health related quality of life in adult atopic dermatitis

BMC Health Services Research, 2023
Background Cost-of-illness studies are widely used for healthcare decision-making in chronic conditions. Our aim was to assess the cost-of-illness of adult atopic dermatitis (AD) from the societal perspective in Hungary.
Zsuzsanna Beretzky, Kamilla Koszorú, Fanni Rencz, Krisztina Hajdu, Júlia Borza, Katalin Bodai, Xu Feifei, Andrea Szegedi, Miklós Sárdy, Valentin Brodszky   +9 more
doaj   +1 more source

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)

Сахарный диабет, 2017
Background: Cost-of-Illness Analysis (COI) constitutes the basis for the decision-making process on the budget and allocation in a modern health care system.
Ivan I. Dedov, Marina F. Kalashnikova, Dmitriy Y. Belousov, Aleksey S. Kolbin, Vladimir V. Rafalskiy, Aleksey E. Cheberda, Mariya A. Kantemirova, Vadim D. Zakiev, Valentin V. Fadeyev   +8 more
doaj   +1 more source

Estimating the Cost of Cervical Cancer Screening in Five Developing Countries [PDF]

, 2010
Background: Cost-effectiveness analyses (CEAs) can provide useful information to policymakers concerned with the broad allocation of resources as well as to local decision makers choosing between different options for reducing the burden from a single ...
Goldhaber-Fiebert, Jeremy D, Goldie, Sue J.   +1 more
core   +1 more source

Community-level expenses for under-5 diarrhoeal cases prior to reporting at Dhaka Hospital: A cross-sectional analysis in Bangladesh

Clinical Epidemiology and Global Health
Background: Diarrhoeal diseases are a major public health challenge, placing immense economic burden on households. We aimed to examine the trends in direct medical costs (DMC), direct non-medical costs (DNMC), and family economic burden (FEB) incurred ...
Md Fuad Al Fidah, Md Ridwan Islam, Md Mushfiqur Rahman, Mohammod Jobayer Chisti, A.S.G. Faruque, Tahmeed Ahmed, Sharika Nuzhat   +6 more
doaj   +1 more source